US 11566072
CD8 binding agents
granted A61KA61K38/191A61K38/20
Quick answer
US patent 11566072 (CD8 binding agents) held by Orionis Biosciences, Inc expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/191, A61K38/20, A61K38/21, A61P